There are 2789 resources available
776P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, for pretreated advanced cervical cancer: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
799P - Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial
Presenter: Wei Wei
Session: ePoster Display
800P - Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario
Presenter: Marco de Scordilli
Session: ePoster Display
801P - Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma
Presenter: Emeline Colomba
Session: ePoster Display
758P - Concordance between multiple HRD assays is substantial in high-grade ovarian cancer
Presenter: Wilko Weichert
Session: ePoster Display
804P - Molecular typing and TMB correlation analysis of endometrial cancer based on targeted NGS
Presenter: JieJie Zhang
Session: ePoster Display
805P - Clinically actionable alterations in adolescents and young adults (AYA) with gynaecological cancers
Presenter: Ainhoa Madariaga Urrutia
Session: ePoster Display
761P - Impact of residual disease on outcomes in patients with ovarian cancer: A meta-analysis
Presenter: Dana Chase
Session: ePoster Display
807P - Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia
Presenter: James Clark
Session: ePoster Display
763P - Treatment response to non-platinum therapies in ovarian cancer patients according to BRCA status: A retrospective analysis of a large multicentric cohort
Presenter: Gaia Giannone
Session: ePoster Display